MedTrace Logo

Long-term Safety and Performance of the ARGOS-SC Suprachoroidal Pressure Sensor System in Patients With Glaucoma Underwent Non-penetrating Glaucoma Surgery

NCT04773106 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 22

Last updated 2025-05-18

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to evaluate the long-term safety and performance of the ARGOS-SC system.

Conditions

Interventions

DEVICE

ARGOS-SC suprachoroidal pressure sensor

The ARGOS-SC pressure sensor was additionally implanted during routine local intraocular pressure lowering procedures in patients with glaucoma undergoing non-penetrating glaucoma surgery in the earlier ARGOS-SC01 study.

Sponsors & Collaborators

  • CRO Dr. med Kottmann GmbH & Co. KG

    collaborator INDUSTRY

  • Implandata Ophthalmic Products GmbH

    lead INDUSTRY

Principal Investigators

  • Peter Szurman, Prof. · Knappschaftsklinikum Saar GmbH

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-02-20
Primary Completion
2023-03-02
Completion
2023-03-02

Countries

  • Germany
  • Switzerland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04773106 on ClinicalTrials.gov